TrialStroke2016

Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.

Gary K Steinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.